APA

Borja-Tabora C. F. C., Montalban C., Memish Z. A., Boutriau D., Kolhe D., Miller J. M. & Van der Wielen M. (20160504). Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial. : BMC infectious diseases.

Chicago

Borja-Tabora Charissa Fay Corazon, Montalban Cecilia, Memish Ziad A, Boutriau Dominique, Kolhe Devayani, Miller Jacqueline M and Van der Wielen Marie. 20160504. Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial. : BMC infectious diseases.

Harvard

Borja-Tabora C. F. C., Montalban C., Memish Z. A., Boutriau D., Kolhe D., Miller J. M. and Van der Wielen M. (20160504). Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial. : BMC infectious diseases.

MLA

Borja-Tabora Charissa Fay Corazon, Montalban Cecilia, Memish Ziad A, Boutriau Dominique, Kolhe Devayani, Miller Jacqueline M and Van der Wielen Marie. Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial. : BMC infectious diseases. 20160504.